Inactive Instrument

Highlights WNTH AB Swiss Exchange

Equities

WNT

SE0003553130

End-of-day quote Swiss Exchange Other stock markets
- ^SEK	-

05-03	WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-29	WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-03	CI
WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-29	CI
WntResearch AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
WntResearch Initiates Collaboration with Business Sweden with the Goal of Establishing Commercial Partnerships for Foxy-5 in Japan and South Korea	02-26	CI
WntResearch AB Continues to the Next Step in the Phase 2 Study Neofox with the Highest Evaluated Dose of Foxy-5	02-12	CI
WntResearch Continues to the Second Dose Group in Clinical Proof of Concept Study of Foxy-5	12-06	CI
WntResearch AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-16	CI
WntResearch AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/08/23	CI
WntResearch AB Announces New Study Plan Approves for Wnt Research's Phase II Study	14/07/23	CI
WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2023	04/05/23	CI
WntResearch AB Reports Earnings Results for the Full Year Ended December 31, 2022	09/02/23	CI
WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	09/02/23	CI
WntResearch AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	17/11/22	CI
WntResearch AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	18/08/22	CI
WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2022	05/05/22	CI
WntResearch AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	09/02/22	CI
WntResearch files a patent application for the treatment of Acute Myeloid Leukemia	13/12/21	CI
WntResearch AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	17/11/21	CI
WntResearch AB Announces Update on Patient Recruitment for the Ongoing Phase IIa Clinical Study Neofox with Wntresearch's Drug Candidate Foxy-5	14/04/21	CI
Wntresearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	08/02/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights WNTH AB Swiss Exchange

Equities

WNT

SE0003553130

Highlights

Filters